Related Experiment Video
Updated: May 6, 2026
Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
Lipid metabolism emerges as a promising target for malignant glioma therapy
Abstract:
Malignant gliomas are one of the most treatment-refractory cancers. Development of resistance to chemo- and radio-therapies contributes to these tumors' aggressive phenotypes. Elevated lipid levels in gliomas have been reported for the last 50 years. However, the molecular mechanisms of how tumor tissues obtain lipids and utilize them are not well understood. Recently, the oncogenic signaling EGFR/PI3K/Akt pathway has been shown to enhance lipid synthesis and uptake by upregulating SREBP-1, a master transcriptional factor, to control lipid metabolism. This article discusses the analytical chemistry results of lipid components in glioma tissues from different research groups. The molecular mechanisms that link oncogenes with lipid programming, and identification of the key molecular targets and development of effective drugs to inhibit lipid metabolism in malignant gliomas will be discussed.
Insights
Malignant gliomas resist treatment due to altered lipid metabolism. Targeting lipid synthesis pathways, like EGFR/PI3K/Akt signaling, offers new therapeutic strategies for these aggressive brain tumors.
Area of Science:
- Oncology
- Cancer Biology
- Biochemistry
Background:
- Malignant gliomas are highly resistant to conventional therapies, with treatment failure linked to tumor cell phenotypes.
- Elevated lipid levels are a long-observed characteristic of gliomas, yet the underlying molecular mechanisms remain unclear.
- The epidermal growth factor receptor (EGFR)/phosphatidylinositol 3-kinase (PI3K)/Akt pathway is implicated in promoting lipid synthesis and uptake.
Purpose of the Study:
- To review analytical chemistry findings on lipid profiles in glioma tissues.
- To elucidate the molecular links between oncogenic signaling and cancer lipid metabolism.
- To identify therapeutic targets for inhibiting lipid metabolism in malignant gliomas.
Main Methods:
- Review of analytical chemistry data on glioma lipid composition from multiple studies.
- Discussion of molecular mechanisms connecting oncogenes to lipid programming.
- Identification of key molecular targets within lipid metabolism pathways.
Main Results:
- The EGFR/PI3K/Akt pathway upregulates sterol regulatory element-binding protein 1 (SREBP-1), a key regulator of lipid synthesis.
- Specific lipid components and their roles in glioma progression are being investigated.
- Analytical chemistry provides crucial data for understanding lipid alterations in tumors.
Conclusions:
- Understanding lipid metabolism reprogramming in gliomas is critical for developing effective treatments.
- Targeting lipid synthesis and uptake pathways presents a promising therapeutic avenue.
- Further research into molecular targets could lead to novel anti-glioma drugs.
